Is there a conflict between the pediatric Panfosol and the New Crown vaccine?

Panfosol, the generic name of which is Bacterial Dissolution Product Capsules, generally does not conflict with the New Crown Vaccine, although the availability of the vaccine has a bearing on the use of the medication. 1. For the prevention of recurrent respiratory infections: Bacterial lysis product capsule is a kind of immunotherapy, which can be used for the prevention as well as treatment of respiratory infections as well as acute exacerbation of chronic bronchitis. Therefore, if children take Bacterial Lysis Product Capsules for the purpose of preventing recurrent respiratory infections, they can be vaccinated with New Crown Vaccine. 2. For the treatment of respiratory tract infections: means that the child is in an acute attack, this time is not suitable for vaccination of the new crown vaccine, need to wait until the child’s condition is cured before vaccination. Bacterial lysis products capsule common adverse reactions include cough, asthma, vomiting, and abdominal pain, etc., for the product ingredients allergy is prohibited. In addition, the application of bacterial lysis products capsule has certain risks, patients need to use the drug under the guidance of a specialist.